West Pharmaceutical Services (WST) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $171.4 million.
- West Pharmaceutical Services' Accumulated Depreciation & Amortization rose 1029.6% to $171.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $171.4 million, marking a year-over-year increase of 1029.6%. This contributed to the annual value of $171.4 million for FY2025, which is 1029.6% up from last year.
- As of Q4 2025, West Pharmaceutical Services' Accumulated Depreciation & Amortization stood at $171.4 million, which was up 1029.6% from $43.0 million recorded in Q3 2025.
- West Pharmaceutical Services' 5-year Accumulated Depreciation & Amortization high stood at $1.3 billion for Q3 2023, and its period low was $35.6 million during Q1 2024.
- Its 5-year average for Accumulated Depreciation & Amortization is $582.7 million, with a median of $163.4 million in 2024.
- Per our database at Business Quant, West Pharmaceutical Services' Accumulated Depreciation & Amortization skyrocketed by 1384.74% in 2023 and then plummeted by 9718.29% in 2024.
- West Pharmaceutical Services' Accumulated Depreciation & Amortization (Quarter) stood at $122.3 million in 2021, then decreased by 1.39% to $120.6 million in 2022, then grew by 13.85% to $137.3 million in 2023, then grew by 13.18% to $155.4 million in 2024, then grew by 10.3% to $171.4 million in 2025.
- Its last three reported values are $171.4 million in Q4 2025, $43.0 million for Q3 2025, and $41.4 million during Q2 2025.